Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × TroVax × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4 Thoracic 1 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1

Conditions

Recurrence 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 269 Carboplatin 265 Cisplatin 192 Bevacizumab 135 pembrolizumab 98 Surveys and Questionnaires 83 Radiotherapy 77 Cyclophosphamide 75 olaparib 68 Blood Specimen Collection 63 Drug Therapy 61 Hyperthermic Intraperitoneal Chemotherapy 60 Gemcitabine 60 niraparib 56 Topotecan 56 Brachytherapy 54 liposomal doxorubicin 53 Taxes 48 Docetaxel 46 Magnetic Resonance Spectroscopy 42 Letrozole 36 Cytoreduction Surgical Procedures 35 Filgrastim 33 Biopsy 33 Surgical Procedures, Operative 32 Doxorubicin 32 durvalumab 31 Specimen Handling 30 Nivolumab 29 Methods 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡